Purple Biotech Ltd (TLV:PPBT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
4.600
-0.100 (-2.13%)
Jul 24, 2025, 5:24 PM IDT
-2.13%
Market Cap24.98M
Revenue (ttm)n/a
Net Income (ttm)-14.64M
Shares Out567.78M
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,871,597
Average Volume1,392,500
Open4.700
Previous Close4.700
Day's Range4.300 - 5.700
52-Week Range3.900 - 21.000
Beta-0.70
RSI54.54
Earnings DateAug 4, 2025

About Purple Biotech

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin recept... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1968
Employees 9
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol PPBT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.